GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » Debt-to-EBITDA

Mach7 Technologies (ASX:M7T) Debt-to-EBITDA : -0.05 (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mach7 Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was A$0.18 Mil. Mach7 Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was A$1.09 Mil. Mach7 Technologies's annualized EBITDA for the quarter that ended in Jun. 2024 was A$-25.93 Mil. Mach7 Technologies's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 was -0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Mach7 Technologies's Debt-to-EBITDA or its related term are showing as below:

ASX:M7T' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.59   Med: -0.08   Max: 0.47
Current: -0.08

During the past 13 years, the highest Debt-to-EBITDA Ratio of Mach7 Technologies was 0.47. The lowest was -0.59. And the median was -0.08.

ASX:M7T's Debt-to-EBITDA is ranked worse than
100% of 447 companies
in the Healthcare Providers & Services industry
Industry Median: 2.45 vs ASX:M7T: -0.08

Mach7 Technologies Debt-to-EBITDA Historical Data

The historical data trend for Mach7 Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies Debt-to-EBITDA Chart

Mach7 Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 -0.59 0.47 -0.14 -0.08

Mach7 Technologies Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.59 0.19 -0.05 -0.25 -0.05

Competitive Comparison of Mach7 Technologies's Debt-to-EBITDA

For the Health Information Services subindustry, Mach7 Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mach7 Technologies's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's Debt-to-EBITDA falls into.



Mach7 Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mach7 Technologies's Debt-to-EBITDA for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.181 + 1.087) / -15.088
=-0.08

Mach7 Technologies's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.181 + 1.087) / -25.928
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2024) EBITDA data.


Mach7 Technologies  (ASX:M7T) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Mach7 Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Mach7 Technologies Business Description

Traded in Other Exchanges
Address
120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialization of medical imaging and data, management software solutions for world-wide healthcare enterprises. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies Headlines

No Headlines